These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 16854324

  • 1. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ, Zhang X, Zhu WL, Huang Y.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1693-6. PubMed ID: 16854324
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR.
    Circulation; 2006 May 02; 113(17):2089-96. PubMed ID: 16636176
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J.
    Tuberculosis (Edinb); 2001 May 02; 81(3):203-9. PubMed ID: 11466032
    [Abstract] [Full Text] [Related]

  • 5. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG.
    J Card Fail; 2002 Dec 02; 8(6):390-8. PubMed ID: 12528092
    [Abstract] [Full Text] [Related]

  • 6. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J, Patal S, Wexler D, Roth A, Sheps D, Keren G.
    Am Heart J; 2005 Sep 02; 150(3):484-7. PubMed ID: 16169329
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
    Jordán A, Roldán V, García M, Monmeneu J, de Burgos FG, Lip GY, Marín F.
    J Intern Med; 2007 Sep 02; 262(3):385-92. PubMed ID: 17697160
    [Abstract] [Full Text] [Related]

  • 8. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ, Spinale FG, Gold MR.
    Am J Cardiol; 2006 Feb 15; 97(4):532-7. PubMed ID: 16461051
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.
    Am Heart J; 2008 Jul 15; 156(1):85-91. PubMed ID: 18585501
    [Abstract] [Full Text] [Related]

  • 10. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG, Gunasinghe H, Sprunger PD, Baskin JM, Bradham WC.
    J Card Fail; 2002 Dec 15; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 15; 27(1):53-61. PubMed ID: 15782494
    [Abstract] [Full Text] [Related]

  • 12. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 15; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM, Yang LX, Zhu SJ, Yang YJ, Guo CM, Qi F, Wei L, Shi YK, Wang Y, Ren L.
    Zhonghua Nei Ke Za Zhi; 2004 Nov 15; 43(11):828-31. PubMed ID: 15634542
    [Abstract] [Full Text] [Related]

  • 15. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S, Kim JO, Methe H.
    Am J Cardiol; 2010 Feb 15; 105(4):429-34. PubMed ID: 20152234
    [Abstract] [Full Text] [Related]

  • 16. [Effects of angiotensin II receptor antagonism on matrix metalloproteinases and fibronectin in rats with experimental myocardial infarction].
    Zhang X, Yang YJ, Zhu WL, Huang Y, Zhu ZM.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov 15; 34(11):1029-34. PubMed ID: 17288771
    [Abstract] [Full Text] [Related]

  • 17. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Goetzenich A, Hatam N, Zernecke A, Weber C, Czarnotta T, Autschbach R, Christiansen S.
    J Heart Lung Transplant; 2009 Oct 15; 28(10):1087-93. PubMed ID: 19782292
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
    Batlle M, Pérez-Villa F, García-Pras E, Lázaro A, Orús J, Roqué M, Roig E.
    Transplant Proc; 2007 Sep 15; 39(7):2344-6. PubMed ID: 17889183
    [Abstract] [Full Text] [Related]

  • 19. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.
    Rheumatology (Oxford); 2006 Apr 15; 45(4):414-20. PubMed ID: 16287916
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W.
    Int J Obes (Lond); 2008 May 15; 32(5):763-71. PubMed ID: 18197181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.